Are GLP-1s Legit? with Dr. Ania Jastrebroff
Summary
Hasan Minhaj explores the science behind obesity and GLP-1 drugs like Ozempic, rejecting the "willpower" myth in favor of biological explanations. He interviews Dr. Anya Jastraboff, who explains how the brain regulates weight through a "set point" and how these medications recalibrate that biological thermostat. The discussion covers the concept of "food noise," the importance of treating obesity as a chronic disease rather than a moral failing, and the potential long-term side effects of these life-changing treatments.
Topics discussed
Sponsor: Ground News and media bias
Intro: Debunking the willpower myth of obesity
The obesogenic environment and historical diet trends
History of diet pills and the rise of GLP-1s
GLP-1 side effects vs. risks of untreated obesity
How GLP-1s work: Set points and food noise
Broader health impacts and patient testimonials
Accessibility, stigma, and the 'weight loss' label
Sponsors: ZipRecruiter and Article
Interview: Defining obesity as a chronic disease
Biology vs. behavior: Why calories in/out fails
The internal weight thermostat and set points
Why the body fights weight loss: Energy conservation
Exercise, health, and the limits of lifestyle changes
Evolutionary biology and the default to weight gain
GLP-1s as recalibrators of the body's set point
Long-term use: Do you have to take them forever?
Sponsors: Abbott Elementary, Rocket, Mint Mobile
Understanding 'food noise' and its disappearance
Obesity as a gateway to preventing other diseases
Managing short-term side effects of GLP-1s
Long-term safety concerns and unknowns
Rare side effects and the culture of pharma ads
Navigating social media, celebrity use, and shame
Sponsors: Article and Huel
Treating the whole person: Eating disorders and mental health
Oprah Winfrey's role in shifting public perception
Building trust in medical treatments amidst hype
Clinical outcomes: Beyond weight loss to health
Conclusion and final thoughts on GLP-1s
Listen ad-free on Castria